Literature DB >> 8062840

The flare phenomenon: far from fair and square.

W D van Schelven, E K Pauwels.   

Abstract

Mesh：

Year:  1994        PMID： 8062840     DOI： 10.1007/bf00171410

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN： 0340-6997


× No keyword cloud information.
  22 in total

1.  Leuprolide therapy for prostate cancer. An association with scintigraphic "flare" on bone scan.

Authors:  W D Johns; M B Garnick; W D Kaplan
Journal:  Clin Nucl Med       Date:  1990-07       Impact factor: 7.794

Review 2.  Bone metastases and breast cancer.

Authors:  R E Coleman; R D Rubens
Journal:  Cancer Treat Rev       Date:  1985-12       Impact factor: 12.111

3.  Effects of radiation therapy on bone lesions as measured by 47 Ca and 85 Sr local kinetics.

Authors:  E J Greenburg; F C Chu; A J Dwyer; E M Ziminski; A B Dimich; J S Laughlin
Journal:  J Nucl Med       Date:  1972-10       Impact factor: 10.057

4.  The predictive value of serial bone scans in assessing response to chemotherapy in advanced breast cancer.

Authors:  J D Bitran; C Bekerman; R K Desser
Journal:  Cancer       Date:  1980-04-01       Impact factor: 6.860

5.  Bone scan flare predicts successful systemic therapy for bone metastases.

Authors:  R E Coleman; G Mashiter; K B Whitaker; D W Moss; R D Rubens; I Fogelman
Journal:  J Nucl Med       Date:  1988-08       Impact factor: 10.057

6.  Changes in 87mSr concentractions in skeletal metastases in patients responding to cyclical combination chemotherapy for advanced breast cancer.

Authors:  P J Gillespie; J L Alexander; G A Edelstyn
Journal:  J Nucl Med       Date:  1975-03       Impact factor: 10.057

7.  Comparative value of bone scintigraphy and radiography in monitoring tumor response in systemically treated prostatic carcinoma.

Authors:  R M Levenson; B J Sauerbrunn; H R Bates; R D Newman; J L Eddy; D C Ihde
Journal:  Radiology       Date:  1983-02       Impact factor: 11.105

8.  The assessment of response to therapy of bone metastases in breast cancer.

Authors:  M A Rossleigh; F T Lovegrove; P M Reynolds; M J Byrne; B P Whitney
Journal:  Aust N Z J Med       Date:  1984-02

9.  The flare phenomenon on radionuclide bone scan in metastatic prostate cancer.

Authors:  J J Pollen; K F Witztum; W L Ashburn
Journal:  AJR Am J Roentgenol       Date:  1984-04       Impact factor: 3.959

10.  The hypercalcemia of malignancy.

Authors:  G R Mundy
Journal:  Kidney Int       Date:  1987-01       Impact factor: 10.612
View more
  4 in total

1.  (68)Ga-PSMA ligand PET versus (18)F-NaF PET: evaluation of response to (223)Ra therapy in a prostate cancer patient.

Authors:  Christian Uprimny; Alexander Kroiss; Bernhard Nilica; Sabine Buxbaum; Clemens Decristoforo; Wolfgang Horninger; Irene J Virgolini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-10-08       Impact factor: 9.236

Review 2.  Estrogen receptor modulators and down regulators: optimal use in postmenopausal women with breast cancer.

Authors:  Christa K Baumann; Monica Castiglione-Gertsch
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Comparison of [68Ga]Ga-PSMA-11 PET/CT with [18F]NaF PET/CT in the evaluation of bone metastases in metastatic prostate cancer patients prior to radionuclide therapy.

Authors:  Christian Uprimny; Anna Svirydenka; Josef Fritz; Alexander Stephan Kroiss; Bernhard Nilica; Clemens Decristoforo; Roland Haubner; Elisabeth von Guggenberg; Sabine Buxbaum; Wolfgang Horninger; Irene Johanna Virgolini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-16       Impact factor: 9.236

Review 4.  Contemporary approaches for imaging skeletal metastasis.

Authors:  David Ulmert; Lilja Solnes; Daniel Lj Thorek
Journal:  Bone Res       Date:  2015-07-14       Impact factor: 13.567
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.